Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Arrhythmias

Free Subscription Articles published in J Cardiovasc Pharmacol Retrieve available abstracts of 21 articles: HTML format

Single Articles

July 2025
1. AVE MT, Brion M, Blanco-Verea A, Gil A, et al
   Relevance of CYP2D6 in the Efficacy and Toxicity of Flecainide in Patients with Atrial Fibrillation: A Cohort Study.
   J Cardiovasc Pharmacol. 2025 Jul 24. doi: 10.1097/FJC.0000000000001739.
   PubMed     Abstract available
   
   
   
2. FAGHIHI M, Ahmadi-Beni M, Houshmand F
   Role of Muscarinic Acetylcholine Receptors in Oxytocin-Induced Cardioprotection Against Ischemia-Reperfusion Injury in Rats.
   J Cardiovasc Pharmacol. 2025;86:109-117.
   PubMed     Abstract available
   
   
   May 2025
3. ATMACA H, Yetkin E
   Coupling Interval Ratio to Predict the Beta-Blocker Response Against Premature Ventricular Complexes.
   J Cardiovasc Pharmacol. 2025;85:364-368.
   PubMed     Abstract available
   
   
   March 2025
4. SAMOS M, Skerenova M, Nosal V, Skornova I, et al
   ABCB1 gene single nucleotide variants and haplotypes in atrial fibrillation patients experiencing adverse events on direct oral anticoagulation: a whole gene exome sequencing study.
   J Cardiovasc Pharmacol. 2025 Mar 28. doi: 10.1097/FJC.0000000000001695.
   PubMed     Abstract available
   
   
   
5. AHUJA T, Saadi R, Papadopoulos J, Bernard S, et al
   Digoxin Loading Doses and Serum Digoxin Concentrations for Rate Control of Atrial Arrhythmias in Critically Ill Patients.
   J Cardiovasc Pharmacol. 2025;85:211-216.
   PubMed     Abstract available
   
   
   January 2025
6. ZHANG X, Liu J, Shi Y, Wang H, et al
   Effect of different doses of dexmedetomidine on atrial fibrillation in adults after cardiac surgery.
   J Cardiovasc Pharmacol. 2025 Jan 23. doi: 10.1097/FJC.0000000000001674.
   PubMed     Abstract available
   
   
   December 2024
7. HAKGOR A, Olgun FE, Dursun A, Kahraman BC, et al
   Sodium glucose cotransporter 2 inhibitors improve long-term atrial fibrillation-free survival after catheter ablation.
   J Cardiovasc Pharmacol. 2024 Dec 31. doi: 10.1097/FJC.0000000000001656.
   PubMed     Abstract available
   
   
   November 2024
8. SCHULZ C, Eschenhagen T, Christ T
   Atrial hiPSC-CM as a Pharmacologic Model to Evaluate Anti-AF Drugs: Some Lessons From I Kur.
   J Cardiovasc Pharmacol. 2024;84:479-485.
   PubMed     Abstract available
   
   
   October 2024
9. DAKROUB A, Beaini H, Kibbi R, Moumneh MB, et al
   Comparative Analysis of Anticoagulation Versus Combination Anticoagulation and Antiplatelet Therapy in Atrial Fibrillation Patients Presenting With Gastrointestinal Bleeding.
   J Cardiovasc Pharmacol. 2024 Oct 10. doi: 10.1097/FJC.0000000000001641.
   PubMed     Abstract available
   
   
   September 2024
10. ISMAILI D, Petersen J, Schulz C, Eschenhagen T, et al
    PDE8 Inhibition and Its Impact on ICa,L in Persistent Atrial Fibrillation: Evaluation of PDE8 as a Potential Drug Target.
    J Cardiovasc Pharmacol. 2024 Sep 13. doi: 10.1097/FJC.0000000000001630.
    PubMed     Abstract available
    
    
    August 2024
11. WU L, Li Z, Xu L, Fan Y, et al
    Nrf2 ameliorates atrial fibrosis during antithrombotic therapy for atrial fibrillation by modulating CYP2C9 activity.
    J Cardiovasc Pharmacol. 2024 Aug 12. doi: 10.1097/FJC.0000000000001618.
    PubMed     Abstract available
    
    
    
12. ZOU Y, Liu X, Hu Y, Zhang C, et al
    Inhibition of alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in Rats with Anxiety Disorders.
    J Cardiovasc Pharmacol. 2024;84:227-238.
    PubMed     Abstract available
    
    
    
13. GOLINO M, Lazzerini PE
    Hydroxychloroquine, Chloroquine, and Arrhythmic Risk in Systemic Autoimmune Diseases: Focus More on the Patient and You Will Keep the Rhythm!
    J Cardiovasc Pharmacol. 2024;84:149-151.
    PubMed    
    
    
    
14. NIKOLIC RPA, Virk MK, Buhler KA, Costenbader KH, et al
    Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients With Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis.
    J Cardiovasc Pharmacol. 2024;84:158-169.
    PubMed     Abstract available
    
    
    July 2024
15. BURASHNIKOV A, Antzelevitch C
    The efficacy of INa block to cardiovert atrial fibrillation is enhanced by inhibition of IK1.
    J Cardiovasc Pharmacol. 2024 Jul 29. doi: 10.1097/FJC.0000000000001617.
    PubMed     Abstract available
    
    
    
16. ZHANG J, Xiong X, Li J, Luo C, et al
    Valtrate suppresses TNFSF14-mediated arrhythmia after myocardial ischemia-reperfusion via inducing N-linked glycosylation of LTbetaR to regulate MGA/MAX/c-Myc/Cx43.
    J Cardiovasc Pharmacol. 2024 Jul 19. doi: 10.1097/FJC.0000000000001613.
    PubMed     Abstract available
    
    
    March 2024
17. CHEN YF, Liu NN, Wang JY, Sun JS, et al
    Use of 3D echocardiography facilitates analysis of thrombolytic efficacy in patients with persistent atrial fibrillation.
    J Cardiovasc Pharmacol. 2024 Mar 25. doi: 10.1097/FJC.0000000000001567.
    PubMed     Abstract available
    
    
    December 2023
18. RIVERA FB, Cha SW, Aparece JP, Jariyatamkitti S, et al
    Efficacy and safety of colchicine for the prevention of postoperative atrial fibrillation among patients undergoing major cardiothoracic surgery: a meta-analysis and meta-regression of randomized controlled trials.
    J Cardiovasc Pharmacol. 2023 Dec 28. doi: 10.1097/FJC.0000000000001533.
    PubMed     Abstract available
    
    
    
19. SPADAFORA L, Gaudio C, Biondi-Zoccai G, Frati G, et al
    Catalysts of cardiovascular electromechanical harmony? Unveiling the impact of RAS Inhibitors and ARNI on atrial fibrillation recurrence after ablation.
    J Cardiovasc Pharmacol. 2023 Dec 27. doi: 10.1097/FJC.0000000000001537.
    PubMed    
    
    
    November 2023
20. SUN Q, Cui W, Zhang X, Tian Y, et al
    A Systematic Review and Meta-analysis of Renin-angiotensin Inhibitors and Angiotensin Receptor Neprilysin Inhibitors in Preventing Recurrence after Atrial Fibrillation Ablation.
    J Cardiovasc Pharmacol. 2023 Nov 22. doi: 10.1097/FJC.0000000000001517.
    PubMed     Abstract available
    
    
    September 2023
21. AMARH E, Tisdale JE, Overholser BR
    Prolonged Exposure to Remdesivir Inhibits the Human Ether-A-Go-Go-Related Gene Potassium Current.
    J Cardiovasc Pharmacol. 2023;82:212-220.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.